The U.S. Equity Portfolio ABBV Holdings History
The U.S. Equity Portfolio's AbbVie Inc Holding Summary
As of 2025-03-31, The U.S. Equity Portfolio held 50,590.00 shares of AbbVie Inc(ABBV), totaling $10.60 Mil. This investment constitutes 0.62% of their stock portfolio, and The U.S. Equity Portfolio now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2020Q2. And since then The U.S. Equity Portfolio has made 5 purchases of ABBV, at an average price of $161.54, for a total of 71,943.00 shares. In addition, there have been 4 sales at an average price of $138.98 for 21,353.00 shares. Based on historical transaction data and ABBV's current price of $191.52, The U.S. Equity Portfolio's estimated gain on his ABBV holdings is $1.03 Mil, reflecting a 8.90% gain to date.
The U.S. Equity Portfolio ABBV ($191.52) Holding Chart
The U.S. Equity Portfolio ABBV ($191.52) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
